A R T I C L E S
Vougioukalakis and Grubbs
transferred in a glovebox, dissolved in the minimum amount of benzene,
and lyophilized to afford the desired complex as a brown-yellow solid
(75 mg, 0.147 mmol, 32% yield). The complex is stable in air in the
solid state and soluble in CH2Cl2, CHCl3, benzene, toluene, and THF.
Crystals suitable for X-ray crystallography were grown at room
temperature by slow diffusion of hexanes into a solution of 6 in
benzene.1H NMR (CD2Cl2, 500 MHz): δ ) 17.93 (s, 1H), 7.90-7.88
(m, 2H), 7.79-7.77 (m, 1H), 7.70-7.58 (m, 4H), 7.15-7.08 (m, 2H),
5.14 (septet, J ) 6 Hz, 1H), 2.42 (s, 3H), 2.12 (s, 3H), 1.52 (d, J ) 6
Hz, 6H); 13C{1H} NMR (CD2Cl2, 125 MHz): δ ) 287.26, 215.05,
154.90, 143.81, 143.80, 142.49, 139.96, 130.36, 129.71, 129.57, 129.18,
122.95, 122.26, 113.68, 75.67, 21.72, 12.97, 12.71. HRMS (FAB+):
calculated for C21H23Cl2NORuS [M]+ 508.9921, observed 508.9900.
ether (1/1) as a brown band. The solvent was removed in vacuo, and
the obtained solid was transferred in a glovebox, dissolved in the
minimum amount of benzene, and lyophilized to afford the desired
complex as a brown solid (74 mg, 0.131 mmol, 58% yield). The
complex is stable in air in the solid state and soluble in CH2Cl2, CHCl3,
benzene, toluene, and THF. Crystals suitable for X-ray crystallography
were grown at room temperature by slow diffusion of hexanes into a
solution of 9 in benzene. 1H NMR (CD2Cl2, 500 MHz): δ ) 17.27 (s,
1H), 7.66-7.62 (m, 2H), 7.54 (t, J ) 8 Hz, 1H), 7.34 (d, J ) 8 Hz,
2H), 7.11-7.06 (m, 2H), 5.16 (septet, J ) 6 Hz, 1H), 2.62 (m, 2H),
2.43 (s, 3H), 2.24 (m, 2H), 1.88 (s, 3H), 1.59 (d, J ) 6 Hz, 6H), 1.17
(t, J ) 7 Hz, 6H); 13C{1H} NMR (CD2Cl2, 125 MHz): δ ) 282.90,
210.53, 154.52, 143.77, 142.20, 140.93, 139.54, 131.26, 130.09, 130.00,
125.80, 122.79, 122.42, 113.65, 75.91, 31.52, 27.39, 27.30, 26.08, 24.06,
21.76, 13.23, 12.71, 12.28. HRMS (FAB+): calculated for C25H30Cl2-
NORuS [M]+ 564.0469, observed 564.0461.
[RuCl2 (3-(2-Methylphenyl)-4,5-dimethylthiazol-2-ylidene) (d
CH-o-iPrOsPh)] 7: This ruthenium complex was prepared and
purified as described for complex 6 (53% yield). Crystals suitable for
X-ray crystallography were grown at room temperature by slow
[RuCl2 (3-(2,6-Diisopropylphenyl)-4,5-dimethylthiazol-2-ylidene)
(dCH-o-iPrOsPh)] 10: 3-(2,6-Diisopropylphenyl)-4,5-dimethylthi-
azolium chloride (14e) (190.8 mg, 0.616 mmol, 2.2 equiv) was stirred
with an equimolar quantity of KHMDS (122.8 mg, 0.616 mmol) in
benzene (15 mL) inside a glovebox at room temperature for 30 min.
Catalyst 4 (168.2 mg, 0.28 mmol, 1.0 equiv) was added as a solid in
one portion, and the reaction flask was taken out of the glovebox and
stirred under a nitrogen atmosphere at room temperature for 1 h. The
solution was concentrated to 2 mL in vacuo and poured onto a column
packed with TSI Scientific silica gel. The complex was eluted with
hexanes/diethyl ether (1/1) as a brown band. The solvent was removed
in vacuo, and the obtained solid was transferred in a glovebox, dissolved
in the minimum amount of benzene, and lyophilized to afford the
desired complex as a brown solid (66 mg, 0.11 mmol, 40% yield).
The complex is stable in air in the solid state and soluble in CH2Cl2,
1
diffusion of hexanes into a solution of 7 in benzene. H NMR (CD2-
Cl2, 500 MHz): δ ) 17.92 (s, 1H), 8.09-8.07 (m, 1H), 7.79-7.77
(m, 1H), 7.70-7.67 (m, 1H), 7.53-7.49 (m, 2H), 7.44-7.42 (m, 1H),
7.15-7.07 (m, 2H), 5.12 (septet, J ) 6 Hz, 1H), 2.42 (s, 3H), 2.16 (s,
3H), 2.01 (s, 3H), 1.53 (d, J ) 6 Hz, 3H), 1.44 (d, J ) 6 Hz, 3H);
13C{1H} NMR (CD2Cl2, 125 MHz): δ ) 287.59, 215.39, 155.27,
144.32, 144.30, 141.81, 140.49, 138.46, 130.70, 130.04, 129.90, 129.52,
123.29, 122.59, 114.02, 76.01, 22.13, 22.07, 19.13, 13.17, 12.36. HRMS
(FAB+): calculated for C22H25Cl2NORuS [M]+ 523.0078, observed
523.0069.
[RuCl2 (3-(2,4,6-Trimethylphenyl)-4,5-dimethylthiazol-2-ylidene)
(dCH-o-iPrOsPh)] 8: In a glovebox, 3-(2,4,6-trimethylphenyl)-4,5-
dimethylthiazolium chloride (14c) (93.8 mg, 0.35 mmol, 1 equiv),
silver(I) oxide (40.6 mg, 0.175 mmol, 0.5 equiv), and 4 Å molecular
sieves (95 mg) were suspended in CH2Cl2 (5 mL) in the dark. The
reaction mixture was stirred at room temperature for 1 h. Catalyst 4
(189 mg, 0.315 mmol, 0.9 equiv) was added as a solid in one portion,
and the reaction flask was taken out of the glovebox and stirred under
a nitrogen atmosphere at room temperature for 1 h in the dark. The
solvent was removed in vacuo, and the remaining solid was dissolved
in a minimum amount of C6H6 and poured onto a column packed with
TSI Scientific silica gel. The complex was eluted with pentanes/diethyl
ether (1/1) as a brown band. The solvent was removed in vacuo, and
the obtained solid was transferred in a glovebox, dissolved in the
minimum amount of benzene, and lyophilized to afford the desired
complex as a brown solid (93 mg, 0.168 mmol, 54% yield). The
complex is stable in air in the solid state and soluble in CH2Cl2, CHCl3,
benzene, toluene, and THF. Crystals suitable for X-ray crystallography
were grown at room temperature by slow diffusion of hexanes into a
solution of 8 in benzene. 1H NMR (CD2Cl2, 500 MHz): δ ) 17.27 (s,
1H), 7.67-7.59 (m, 2H), 7.12-7.07 (m, 4H), 5.17 (septet, J ) 6 Hz,
1H), 2.43 (s, 6H), 2.09 (s, 6H), 1.87 (s, 3H), 1.61 (d, J ) 6 Hz, 6H);
13C{1H} NMR (CD2Cl2, 125 MHz): δ ) 284.03, 211.33, 154.36,
143.92, 140.58, 139.78, 138.08, 137.00, 130.82, 130.10, 129.31, 122.81,
122.43, 113.62, 75.93, 21.74, 21.19, 18.71, 12.69, 11.90. HRMS
(FAB+): calculated for C24H29Cl2NORuS [M]+ 551.0391, observed
551.0382.
1
CHCl3, benzene, toluene, and THF. H NMR (CD2Cl2, 500 MHz): δ
) 16.60 (s, 1H), 7.63-7.57 (m, 2H), 7.38 (d, J ) 8 Hz, 2H), 7.07-
7.02 (m, 3H), 5.19 (septet, J ) 6 Hz, 1H), 2.50 (septet, J ) 7 Hz, 2H),
2.42 (s, 3H), 1.91 (s, 3H), 1.70 (d, J ) 6 Hz, 6H), 1.12 (d, J ) 7 Hz,
6H), 1.03 (d, J ) 7 Hz, 6H); 13C{1H} NMR (CD2Cl2, 125 MHz):
280.83, 209.03, 162.87, 154.15, 146.64, 143.30, 141.88, 138.53, 130.42,
129.81, 124.75, 122.63, 122.29, 113.50, 75.93, 28.41, 24.46, 24.12,
22.02, 12.99, 12.58. HRMS (FAB+) calculated for C27H35NOCl2RuS
[M]+ 593.0860, observed 593.0875.
[RuCl2 (3-(2,4,6-Trimethylphenyl)-4,5-dimethylthiazol-2-ylidene)
(dCHsPh) (PCy3)] 11: In a glovebox, 3-(2,4,6-trimethylphenyl)-4,5-
dimethylthiazolium chloride (14c) (134 mg, 0.5 mmol, 1 equiv), silver-
(I) oxide (58 mg, 0.25 mmol, 0.5 equiv), and 4 Å molecular sieves
(135 mg) were suspended in CH2Cl2 (2.5 mL) in the dark. The reaction
mixture was stirred at room temperature for 1 h. Catalyst 2 (370 mg,
0.45 mmol, 0.9 equiv) was added as a solid in one portion, and the
reaction flask was taken out of the glovebox and stirred under a nitrogen
atmosphere at room temperature for 30 min in the dark. The solvent
was removed in vacuo, and the remaining solid was dissolved in a
minimum amount of C6H6 and poured onto a column packed with TSI
Scientific silica gel. The complex was eluted with diethyl ether/pentanes
(15/85) as a green band. The solvent was removed in vacuo, and the
obtained solid was transferred in a glovebox, dissolved in the minimum
amount of benzene, and lyophilized to afford the desired complex as
a brown solid (105 mg, 0.136 mmol, 30% yield). The complex is stable
in air in the solid state and soluble in CH2Cl2, CHCl3, benzene, toluene,
[RuCl2 (3-(2,6-Diethylphenyl)-4,5-dimethylthiazol-2-ylidene)
(dCH-o-iPrOsPh)] 9: In a glovebox, 3-(2,6-diethylphenyl)-4,5-
dimethylthiazolium chloride (14d) (70.5 mg, 0.25 mmol, 1 equiv),
silver(I) oxide (29.0 mg, 0.125 mmol, 0.5 equiv), and 4 Å molecular
sieves (71 mg) were suspended in CH2Cl2 (3.5 mL) in the dark. The
reaction mixture was stirred at room temperature for 1 h. Catalyst 4
(135 mg, 0.225 mmol, 0.9 equiv) was added as a solid in one portion,
and the reaction flask was taken out of the glovebox and stirred under
a nitrogen atmosphere at room temperature for 16 h in the dark. The
solvent was removed in vacuo, and the remaining solid was dissolved
in a minimum amount of C6H6 and poured onto a column packed with
TSI Scientific silica gel. The complex was eluted with pentanes/diethyl
1
and THF. H NMR (CD2Cl2, 500 MHz): δ ) 19.61 (d, J ) 6 Hz,
1H), 8.16 (d, J ) 8 Hz, 2H), 7.59 (t, J ) 8 Hz, 1H), 7.29 (t, J ) 8 Hz,
2H), 6.84 (s, 2H), 2.34-2.24 (m, 9H), 2.11 (s, 6H), 1.77 (s, 3H), 1.71-
1.12 (m, 30H); 13C{1H} NMR (CD2Cl2, 125 MHz): δ ) 299.80, 220.39,
152.21, 140.31, 139.14, 137.94, 136.21, 131.24, 129.71, 129.46, 128.44,
107.27, 32.53, 32.40, 29.96, 28.08, 28.00, 27.21, 26.66, 21.08, 18.88,
12.35, 11.67; 31P{1H} NMR (CD2Cl2, 202 MHz) δ ) 30.96. HRMS
(FAB+): calculated for C39H56Cl2NPSRu [M]+ 773.2292, observed
773.2316.
9
2244 J. AM. CHEM. SOC. VOL. 130, NO. 7, 2008